𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells

✍ Scribed by Mahvash Zakikhani; Marie-José Blouin; Esther Piura; Michael N. Pollak


Publisher
Springer US
Year
2010
Tongue
English
Weight
492 KB
Volume
123
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


IGF-1 activates hEAG K+ channels through
✍ Anne-Sophie Borowiec; Frédéric Hague; Noria Harir; Stéphanie Guénin; François Gu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB

## Abstract Previous work from our laboratory has shown that human ether à go‐go (hEAG) K^+^ channels are crucial for breast cancer cell proliferation and cell cycle progression. In this study, we investigated the regulation of hEAG channels by an insulin‐like growth factor‐1 (IGF‐1), which is know

Effects of tyrosine kinase inhibitors on
✍ Jeffrey W. Clark; Anabela Santos-Moore; Lisa E. Stevenson; A. Raymond Frackelton 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 698 KB

Breast cancers frequently over-express a number of growth factor receptors. In addition, elevated src family kinase activity is present in a percentage of these neoplasms and has been implicated in signal transduction in these cells. Therefore, inhibiting tyrosine kinase activity is a potential appr

Rapamycin potentiates the effects of pac
✍ Aaron Shafer; Chunxiao Zhou; Paola A. Gehrig; John F. Boggess; Victoria L. Bae-J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 747 KB

## Abstract Mammalian target of rapamycin (mTOR) inhibitors modulate signaling pathways involved in cell cycle progression, and recent phase II trials demonstrate activity in patients with endometrial cancer. Our objective was to examine the effects of combination therapy with rapamycin and paclita